We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -8.00 | -0.07% | 12,016.00 | 12,016.00 | 12,020.00 | 12,066.00 | 11,944.00 | 11,950.00 | 159,301 | 09:15:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.35 | 186.7B |
From Apr 2019 to Apr 2024
By Denise Roland
AstraZeneca PLC said stockpiling of medicines boosted first-quarter sales but warned it was hard to predict the overall impact of the coronavirus pandemic.
The British drugmaker on Wednesday said the longer-term impact of the pandemic was "highly uncertain" with any damaging ramifications for the company depending on its duration, extent and severity. It added that the pandemic could hurt drug development, new medicine launches and the manufacturing or supply of medicines. For now, the company has retained its full-year guidance.
AstraZeneca said revenue in the three months to March 31 rose 17% at constant currencies to $6.4 billion. It attributed a low-to-mid single-digit percentage of that growth to patients filling their prescriptions for longer periods because of the pandemic. It expects that effect to reverse in the coming months.
Net profit rose 32% to $780 million, largely thanks to higher sales and proceeds from licensing deals. Core earnings per share, a measure that strips out one-time items, rose 21% to $1.05.
Write to Denise Roland at denise.roland@wsj.com
(END) Dow Jones Newswires
April 29, 2020 03:40 ET (07:40 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
